#ELEG Electric Guitar PLC – 3radical Limited to be placed into administration November 28, 2024 – Posted in: Electric Guitar Plc (ELEG)

Electric Guitar PLC (LSE: ELEG), the digital marketing and advertising company providing first-party data solutions, announces that the Board of 3radical Limited (“3radical”), Electric Guitar’s principal trading subsidiary, has instructed Paul Ellison and Christopher Errington of KRE Corporate Recovery Limited (“KRE”) to market the business and assets of 3radical for sale, in anticipation of their being appointed as 3radical’s Administrators and completing a pre-packaged sale of the business and assets on a going concern basis…

#POLB Poolbeg Pharma PLC – POLB 001 Patent Granted in United States November 20, 2024 – Posted in: Poolbeg Pharma (POLB)

20 November 2024- Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that the US Patent Office has notified the Company of its official decision to grant Poolbeg’s US Immunomodulator I patent application. The claims cover POLB 001, and other p38 MAP kinase inhibitors, for the treatment of patients at risk of severe influenza after an…

#ENSI EnSilica PLC – Post Quantum Cryptography Accelerators IP Release January 12, 2024 – Posted in: Vela Technologies Plc (VELA)

EnSilica (AIM: ENSI), a leading chip maker of mixed-signal ASICs (Application Specific Integrated Circuits), is pleased to announce the release of a range of Post-Quantum Cryptography (“PQC”) accelerators, with the first of these intellectual property (“IP”) licenses granted to a major semiconductor supplier. EnSilica is one of the few companies to offer advanced cryptographic accelerators1 to the market as licensable IP cores, expanding EnSilica’s comprehensive range of non-quantum resistant cryptography accelerators for use…

#TSP TruSpine Technologies PLC – Half-year Report December 28, 2023 – Posted in: Blog, TruSpine Plc (TSP)

CHIEF EXECUTIVE’S REPORT During the period under review and the period to date the Company is pleased to have made progress on three fronts namely :- – the FDA submission is progressing and has now reached the substantive phase which it is currently undergoing and the Company is hoping for more positive news in the New Year. – Following the registration of its IP title, the Company anticipates signing a distribution agreement in 2024. – …

#TSP TruSpine Technologies PLC – IP Registration October 25, 2023 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems announces that it has, with the help of the Company’s newly appointed IP lawyers, published the original assignment of the Intellectual Property Rights to the Company as per the Original IP Agreement and Addendum. The patents acquired as part of the Intellectual Property Rights can be viewed at the following link: https://assignment.uspto.gov/patent/index.html#/patent/search/resultAssignee?assigneeName=TRUSPINE%20TECHNOLOGIES%20LIMITED Capitalised terms…

#VELA investee co. #TSP TruSpine Technologies PLC – Update re Loan May 9, 2023 – Posted in: TruSpine Plc (TSP), Vela Technologies Plc (VELA)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces an update to the announcement released by the Company on 28 February 2023 in relation to the Loan Agreement entered into by the Company. The announcement of 28 February 2023 omitted to disclose a fixed and floating charge over the Company’s intellectual property to the lender as security for the proceeds of which were received on 27 February 2023.…

#POLB Poolbeg Pharma – POLB 001 Patent Portfolio Strengthened March 8, 2023 – Posted in: Poolbeg Pharma (POLB)

Key highlights · Patent granted for use of certain p38 MAP kinase inhibitors for the treatment of hypercytokinaemia · Allows for use in combination with an antiviral agent · Patent enhances the robust IP portfolio protecting Poolbeg’s growing pipeline 8 March 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading infectious disease focused biopharmaceutical company, announces that further to its announcement on 4 October 2022, it has been granted a patent by the US Patent and Trademark Office (USPTO)…

#TM1 Technology Minerals – Q&A: Building battery recycling capabilities December 9, 2021 – Posted in: Blog, Technology Minerals (TM1)

Technology Minerals is a London-based, LSE-listed company creating a circular economy for battery metals. The company, which is also engaged in extracting raw materials required for lithium-ion (Li-ion) battery cathodes, plans to increase its lead-acid battery recycling capability to 16,000 tonnes per annum by 2022, and 5,000 tonnes per annum for Li-ion batteries in the same time frame. Robin Brundle, chairman of Technology Minerals plc, outlines TM’s plans to recycle batteries on an industrial scale. …

#ELEG Electric Guitar PLC – 3radical Limited to be placed into administration November 28, 2024 – Posted in: Electric Guitar Plc (ELEG)

#POLB Poolbeg Pharma PLC – POLB 001 Patent Granted in United States November 20, 2024 – Posted in: Poolbeg Pharma (POLB)

#ENSI EnSilica PLC – Post Quantum Cryptography Accelerators IP Release January 12, 2024 – Posted in: Vela Technologies Plc (VELA)

#TSP TruSpine Technologies PLC – Half-year Report December 28, 2023 – Posted in: Blog, TruSpine Plc (TSP)

#TSP TruSpine Technologies PLC – IP Registration October 25, 2023 – Posted in: Blog, TruSpine Plc (TSP)

#VELA investee co. #TSP TruSpine Technologies PLC – Update re Loan May 9, 2023 – Posted in: TruSpine Plc (TSP), Vela Technologies Plc (VELA)

#POLB Poolbeg Pharma – POLB 001 Patent Portfolio Strengthened March 8, 2023 – Posted in: Poolbeg Pharma (POLB)

#TM1 Technology Minerals – Q&A: Building battery recycling capabilities December 9, 2021 – Posted in: Blog, Technology Minerals (TM1)

Address

Contact

Social

LEGAL